Search results
Results from the WOW.Com Content Network
These two studies are some of the first large controlled studies measuring the effects of psychedelic therapy on depression and anxiety in cancer patients. [66] Across clinician-ratings and self-ratings, the psychedelic treatment produced statistically significant lowered anxiety and depression, with sustenance for at least 6 months.
Because most psychedelics are controlled substances in the US, there are concerns for their use in treating mental health disorders, including trauma-related disorders. Adverse effects and addiction are significant concerns people have when discussing psychedelics for the benefit of treatment.
Psilocybin therapy is the use of psilocybin (the psychoactive ingredient in psilocybin mushrooms) in treating a range of mental health conditions, such as depression, anxiety, addictions, [1] obsessive compulsive disorder (OCD), and psychosis. [2] It is one of several forms of psychedelic therapy under study.
Psilocybin is the psychedelic component of magic mushrooms and a synthetic version of it coupled with intensive therapy is in clinical trials at Ohio State, said Dr. Alan Davis, an associate ...
Ketamine-assisted psychotherapy (KAP) is the use of prescribed doses of ketamine as an adjunct to psychotherapy sessions. KAP shows significant potential in treating mental disorders such as treatment-resistant depression (TRD), anxiety, obsessive–compulsive disorders (OCD), post-traumatic stress disorders (PTSD), and other conditions. [1]
Over the last five years, research on psychedelic drugs as part of a therapy for mental conditions such as post-traumatic stress disorder, depression, anxiety and addiction has exploded.
Psychedelic therapy (or psychedelic-assisted therapy) refers to the proposed use of psychedelic drugs, such as psilocybin, MDMA, [note 2] LSD, and ayahuasca, to treat mental disorders. [ 58 ] [ 59 ] As of 2021, psychedelic drugs are controlled substances in most countries and psychedelic therapy is not legally available outside clinical trials ...
Australia is now the first country to allow psychiatrists to prescribe certain psychedelic substances to patients with depression or post-traumatic stress disorder. Beginning Saturday, Australian ...